glp-1 medications approved for type 2 diabetes 2025 How Employers Can Manage Costs in Their Health Plans Semaglutide & tirzepatide are transforming

Existing workplace protection measures, though technically effective, often face economic barriers that prevent widespread adoption, particularly in resource-limited settings

Some injectable GLP-1 receptor agonists (such as liraglutide, dulaglutide, and injectable semaglutide) have demonstrated cardiovascular benefits in clinical trials

The goal is not a full normal day of eating

If you're concerned about testing, check with your employer or regulatory body for clarification.

Both are known to treat obesity or overweight, aiding in weight loss, with an average decrease in body weight of 14.9%.* Your BMI is used to determine eligibility for one of our GLP-1 Plans

Ferreira GC et al